Crossref
Problems with FIB-4 as an initial screening tool for liver fibrosis in patients with type 2 diabetes
Metabolism and Target Organ Damage · 08.07.2026 · 6 (3)
DOI: 10.20517/mtod.2026.92 ↗Kurz gefasst
Fachartikel in der Zeitschrift Metabolism and Target Organ Damage, online erschienen am 08.07.2026. Verfasst von Josh Bilson und 2 weiteren Autor:innen. Die Arbeit nennt 33 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Bilson, J., Buchanan, R. M., & Byrne, C. D. (2026). Problems with FIB-4 as an initial screening tool for liver fibrosis in patients with type 2 diabetes. Metabolism and Target Organ Damage, 6(3). https://doi.org/10.20517/mtod.2026.92
Vancouver
Bilson J, Buchanan RM, Byrne CD. Problems with FIB-4 as an initial screening tool for liver fibrosis in patients with type 2 diabetes. Metabolism and Target Organ Damage. 2026;6(3). doi:10.20517/mtod.2026.92
BibTeX
@article{Bilson2026,
author = {Bilson, Josh and Buchanan, Ryan M. and Byrne, Christopher D},
title = {Problems with FIB-4 as an initial screening tool for liver fibrosis in patients with type 2 diabetes},
journal = {Metabolism and Target Organ Damage},
year = {2026},
volume = {6},
number = {3},
doi = {10.20517/mtod.2026.92}
}
EUVIMED